NEW YORK (AP) - Three studies released Friday offered more evidence that COVID-19 vaccines are standing up to the omicron variant, at least among people who received booster shots. They are the first large U.S. studies to look at vaccine protection against omicron, health officials said.
The papers echo previous research — including studies in Germany, South Africa and the U.K. — indicating available vaccines are less effective against omicron than earlier versions of the coronavirus, but also that boosters significantly improve protection.
The first study looked at hospitalizations and emergency room and urgent care center visits in 10 states, from August to this month.
It found vaccine effectiveness was best after three doses of the Pfizer or Moderna vaccines in preventing COVID-19-associated emergency department and urgent care visits. Protection dropped from 94% during the delta wave to 82% during the omicron wave. Protection from just two doses was lower, especially if six months had passed since the second dose.
Get breaking news alerts in the free FOX5NY News app | Sign up for FOX 5 email newsletters
Related Stories
- Omicron may have been in NYC before it was discovered in South Africa
- How will the world decide when the pandemic is over?
- Pandemic triggered children's mental health emergency, groups say
- What are COVID-19 breakthrough cases?
- How the coronavirus pandemic can attack your mental health
- WHO chief: Science delivered but politics triumphed amid pandemic
The second study focused on COVID-19 case and death rates in 25 states from the beginning of April through Christmas. People who were boosted had the highest protection against coronavirus infection, both during the time delta was dominant and also when omicron was taking over.
Those two articles were published online by the Centers for Disease Control and Prevention.
The Journal of the American Medical Association published the third study, also led by CDC researchers. It looked at people who tested positive for COVID-19 from Dec. 10 to Jan. 1 at more than 4,600 testing sites across the U.S.
Three shots of the vaccines were about 67% effective against omicron-related symptomatic disease compared with unvaccinated people. Two doses, however, offered no significant protection against omicron, the researchers found.
"It really shows the important of getting a booster dose," said the CDC's Emma Accorsi, one of the study's authors.
The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.
This browser does not support the Video element.
Vaccine Breakthrough COVID
Being vaccinated against COVID-19 doesn't guarantee that you won't get infected. But here is why getting vaccinated helps protect you anyway and is so crucial to ending the pandemic.